Click For Photo: https://static-thechristianpost.netdna-ssl.com/files/original/thumbnail/22/93/229346.jpg
We've compiled the top stories of the week. Here's what you need to know:
Three major conferences drew tens of thousands of college students around the start of the new year, all with the aim of helping the younger generation leverage their lives for God and whatever He is calling them to.
InterVarsity - Urbana - Student - Missions - Conference
InterVarsity’s Urbana, a student missions conference, kicked it off at the end of 2018 in St. Louis, followed by Louie Giglio’s Passion in Atlanta, and The Gospel Coalition’s Cross Conference in Louisville, Kentucky.
“What victory looks like … it’s not the honors and splendors of the earth. It’s making a difference. It’s bringing the hope and the salvation of Christ to others. It’s helping a constellation of people around you flourish. Aim higher, see further, run a grander race,” said René Breuel, pastor of Hopera Church in Rome, Italy, at Urbana.
Post - Feature - Dangers - Lupron - Drug
The Christian Post ran an exclusive feature on the dangers of administering Lupron, a drug used to fight prostate cancer, to children with gender dysphoria. Doctors have been distributing the puberty blocker despite the lack of peer-reviewed studies and the absence of FDA approval (for that purpose).
"There have been few physicians willing to stand up and say, 'We need to question this, there is something wrong here. Why are we using cancer drugs on kids without cancer and stopping normal puberty?’” said Dr. Michael Laidlaw.
Doctors - CP - Argue - Drug
The doctors CP spoke with argue that the drug is permanently damaging...
Wake Up To Breaking News!